AHIP, PhRMA Try to Control Narrative as Heat on PBMs Intensifies

Pills in dollars
With the spotlight on PBMs, AHIP appears to be trying to prevent spillover. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Legislation

More from Pink Sheet